What Happens After Ovarian Cancer Treatment?
You’ve been treated for ovarian cancer. Now what? You may have questions about maintenance therapy, surveillance guidelines after initial treatment, tests you may receive, how to watch for symptoms that could indicate a recurrence, and more. Dr. Brittany Lees, a gynecologic oncologist at Atrium Health Levine Cancer Institute, will delve into what happens after treatment […]
In a Nutshell: HIPEC and Ovarian Cancer
Hyperthermic intraperitoneal chemotherapy (HIPEC), also known as “hot chemotherapy,” is a treatment for ovarian cancer, but it is controversial. In this brief conversation with Dr. Ernest Han, a gynecologic oncologist at City of Hope, we’ll discuss HIPEC, how it works, what the research says, and why there is a lack of consensus surrounding this treatment […]
Language Access: Understanding Your Rights
Getting a cancer diagnosis can be scary, especially if you don’t speak the same language as your healthcare team. But everyone deserves good care, and there are resources to help you understand your options in any language. Join us for a special talk about patient rights, language access, and how to speak up to make […]
Cannabis for Chronic Pain Management
Pain is a common challenge for many cancer patients, particularly those experiencing severe joint or nerve pain from medications aimed at reducing recurrence or managing ongoing treatment. Join us for an insightful session with Kevin Boehnke, PhD, an Assistant Professor from the University of Michigan’s Chronic Pain & Fatigue Research Center who is also a […]
Fertility-Sparing Treatment for Gynecologic Cancer
For those of reproductive age who want to have biological children, fertility is a vital consideration following a diagnosis of gynecologic cancer. While treatment is essential for survival, it can impact reproductive health. Join Dr. Katherine Mager, a gynecologic oncologist at Roswell Park Comprehensive Cancer Center, for an engaging discussion on fertility-sparing treatment of gynecologic […]
SABCS 2024 Roundup: What’s the Latest in Metastatic Breast Cancer (MBC)
Join us for a summary of the latest developments in MBC research presented at the annual San Antonio Breast Cancer Symposium (SABCS), 2024. Dr. Debu Tripathy, breast oncologist at The University of Texas MD Anderson Cancer Center, will break down the data, explain what it means, and answer questions. Key Takeaways from this Webinar: Ember-3 […]
Immunotherapy and Uterine Cancer: What Patients Should Know
Immunotherapy is a type of cancer treatment that uses the body’s immune system to fight cancer cells. Advances in immunotherapy over the last few years have been game-changing for the treatment of uterine cancer, particularly in advanced or recurrent disease. Dr. Emily Hinchcliff, gynecologic oncologist at Northwestern Medical Group, will discuss the various immunotherapy treatments […]
Biomarkers and Ovarian Cancer Treatment: What You Need to Know
Biomarkers play an essential role in ovarian cancer treatment and the evolution of personalized medicine. At the same time, understanding how various biomarkers can inform your treatment options can be confusing. In this webinar, Dr. Leslie Boyd, Director of Gynecologic Oncology at Perlmutter Cancer Center, will help make sense of it all by providing an […]
The Latest Treatments for Uterine Cancer and What’s in the Pipeline
Uterine cancer molecular categories now drive many treatment options. Join Dr. Gottfried Konecny, gynecologic medical oncologist and professor at UCLA Health, as he explains new treatments that span across molecular categories, with a particular emphasis on the No Specific Mutational Profile (NSMP). Of the four molecular categories for uterine cancer, over 50% of endometrial cancers […]
